TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
ZBIO

Zenas BioPharma, Inc.

Healthcare · Biotechnology

29.60$ -10.3% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ZBIO
Line item 2022 2023 2024 2025
-90.0% +100.0%
-99.8% +123,031.9% -100.0%
-368.3%
-4.2% +131.8% +20.8%
+33.6% +68.6% +84.8%
+500.6% -65.9% +644.2%
+42.5% -118.4%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?